Trial Design
HYPERTENSION
A 2-arm, parallel, prospective randomized controlled trial (retrospectively registered in the Chinese Clinical Trial Registry: ChiCTR1900026437) was conducted to assess the 6-month effects of an mHealth app–based intervention for patients’ self-management of hypertension. The intervention was compared with usual care (control) measures at baseline and 6 months after implementation. The study followed the guidelines for reporting parallel group randomized controlled trials [